EGFR and neoplasm: Cells from CLH21, a relapsed LAC tumor harboring EGFR-T790M mutation, were not sensitive to Cyclopamine or HHIP overexpression, presumably due to the T790M-driven EGFR activation that maintained cell survival (Supplementary Table S1 and Figure 7C–7E).